Research-Grade Peptides — >99% Purity, Third-Party Tested. Free 2-Day Shipping on Orders $199+
Research Comparison

Melanotan II vs Melanotan I (Afamelanotide)

Melanotan II and Melanotan I (also known as Afamelanotide) are both synthetic analogs of alpha-melanocyte-stimulating hormone (alpha-MSH) investigated in melanocortin receptor research. They share a common origin but differ in receptor selectivity and research profiles. Researchers studying melanocortin pathways frequently consider both.

PropertyMelanotan IIMelanotan I
Other namesMT-II, MT2Afamelanotide, Scenesse
Classalpha-MSH analog (cyclic)alpha-MSH analog (linear)
Receptor selectivityBroad: MC1R, MC3R, MC4R, MC5RMore selective for MC1R
Primary research focusMelanocortin pathways broadlyPhotoprotection, MC1R research
Half-life (reported)~33 minutesLonger, sustained release form

About Melanotan II

Melanotan II is a synthetic cyclic heptapeptide analog of alpha-MSH. Research has characterized it as broadly active across melanocortin receptors (MC1R through MC5R), making it useful for research investigating multiple melanocortin pathways. Its broader receptor profile distinguishes it from the more selective Melanotan I.

About Melanotan I (Afamelanotide)

Melanotan I, also known as Afamelanotide, is a synthetic linear tridecapeptide analog of alpha-MSH. Research has characterized it as more selective for the MC1R receptor compared to Melanotan II. It has clinical research history particularly in photoprotection research and has received clinical approval in certain indications.

Which Should Researchers Choose?

The choice depends on the research mechanism of interest:

  • Broad melanocortin receptor research -> Melanotan II.
  • MC1R-selective research -> Melanotan I.
  • Photoprotection research -> Melanotan I has more clinical research history in this area.

Frequently Asked Questions

Are Melanotan I and II the same compound?

No. They share an origin as alpha-MSH analogs but differ in structure and receptor selectivity.

Which is more researched?

Melanotan I has more clinical research history; Melanotan II is more common in broader melanocortin research.

Are these FDA approved?

Melanotan I (Afamelanotide) has clinical approval in some specific indications. Melanotan II is an investigational research compound.

Research use only. All products and content are intended strictly for laboratory and research use. Not for human consumption. The information provided is summarized from published research literature and does not constitute medical advice.

Other Comparisons